Senate Holds Confirmation Hearing For Trump CDC Nominee Erica Schwartz
The Senate Health, Education, Labor and Pensions Committee held a confirmation hearing Wednesday, July 15, 2026, for CDC director nominee Dr. Erica Schwartz in Washington, as senators pressed her on vaccine policy and agency leadership.[1]
Schwartz is a retired U.S. Public Health Service rear admiral, a former Coast Guard chief medical officer and a former deputy surgeon general, and she has publicly supported vaccines.[1] She was nominated by President Trump on April 16 and is his third CDC pick; the agency has lacked a permanent director for most of his second term.[1]
President Trump took office for his second term in January 2025. The White House withdrew its first nominee, former Florida congressman Dave Weldon, in March 2025 after his confirmation hearing was canceled. Susan Monarez was confirmed in July 2025 but was ousted the following month amid reported disagreements with HHS Secretary Robert F. Kennedy Jr. Acting directors included Deputy HHS Secretary Jim O'Neill and later NIH Director Jay Bhattacharya. On April 16, 2026, the White House announced Schwartz as the nominee. In March 2026 a federal judge in Massachusetts issued a preliminary injunction blocking Kennedy's changes to the childhood immunization schedule and his reconstitution of the CDC's vaccine advisory committee.
The CDC director job became subject to Senate confirmation after a 2023 law, making Schwartz's hearing among the first under the new requirement. The agency requested 9,754 full-time positions and sought about $4.243 billion in discretionary funds for fiscal 2026, resources a confirmed director would oversee.
The mainstream summary does not mention the significant legislative change that made the CDC director position subject to Senate confirmation, a shift that underscores the heightened scrutiny surrounding Schwartz's nomination. This new requirement, effective only since 2023, positions her confirmation hearing among the first under this law, indicating a notable evolution in how public health leadership is vetted and approved.[2]
Additionally, while the summary notes the CDC's request for funding and positions, it lacks context about the broader crisis of trust in public health agencies, particularly the CDC. A recent Harvard poll reveals a dramatic decline in trust in CDC recommendations, with approval ratings plummeting from 92% to 34% among Democrats and from 77% to 47% among Independents from 2025 to 2026. This erosion of trust is attributed to partisan divides and perceptions that agency actions are overly influenced by personal beliefs, a complex backdrop that Schwartz will need to navigate if confirmed.[3]
Show source details & analysis (1 source)
📊 Relevant Data
The CDC director position became subject to Senate confirmation only after 2023 legislation; previously the president appointed the director without Senate approval, and Schwartz's hearing is among the first under the new requirement.
CDC requested 9,754 full-time equivalent positions for FY 2026, with an enacted discretionary budget authority of approximately $4.243 billion plus evaluation funds.
📌 Key Facts
- On Wednesday, July 15, 2026, the Senate HELP Committee is holding a confirmation hearing for CDC director nominee Dr. Erica Schwartz.
- Schwartz was nominated in mid-April 2026 and is Trump’s third CDC pick; the agency has lacked a permanent director for most of his second term.
- Schwartz is a retired U.S. Public Health Service rear admiral, former Coast Guard chief medical officer, former deputy surgeon general, and a public supporter of vaccines.
- If confirmed, she will serve under HHS Secretary Robert F. Kennedy Jr., whose attempted vaccine policy changes have been largely blocked in court.
📰 Source Timeline (1)
Follow how coverage of this story developed over time